“Outcry Over EpiPen Prices Hasn’t Made Them Lower,” is the misleading headline over Charles Duhigg’s “Adventures in Capitalism” column in The New York Times business section. Duhigg writes, “I was surprised when my pharmacist informed me, months...
Read full post here:
https://skpsoft.com/media/epipen-not-overpriced-despite-new-york-times-complaint/
Tuesday, June 6, 2017
EpiPen Not Overpriced, Despite New York Times Complaint
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment